“…Ω, based in the literature found for each system. Substrate nomenclature adapted from [ 54 ]: AC, acriflavine; AG, aminoglycosides; BI, bicyclomycin; BL, beta-lactams; BS, bile salts; BENZ, benzalkonium chloride; CCC, carbonyl cyanide chlorophenylhydrazone; CM, chloramphenicol; CV, crystal violet; DC, deoxycholate; EB, ethidium bromide; EM, erythromycin; ENX, enoxacin; FA, fatty acids; FQ, fluoroquinolones; FOM, fosfomycin; FM, fosmidomycin; FU, fusidic acid; ML, macrolides; NA, nalidixic acid; NFX, norfloxacin; NO, novobiocin; OS, organic solvents; RD, rhodamine; RF, rifampicin; SDS, sodium dodecyl sulfate; STZ, sulfathiazole; TC, tetracycline; TCS, tetrachlorosalicylanilide; TLM, thiolactomycin; TPP, tetraphenylphosphonium chloride; TX, Triton X-100; ?, regarded as related to multidrug-resistance, but with an unknown resistance spectrum. *, evaluated by BLASTP against the target genome.…”